SURVEY ON β-LACTAM ANTIBIOTIC RESISTANCE IN ENTERIC BACTERIA ISOLATED AT HAI DUONG GENERAL HOSPITAL, 2020–2022

Thị Hồng Quyên Nguyễn 1,, Đức Trưởng Nguyễn 2, Thị Luyện Phùng 1
1 Haiduong Medical Technical University
2 Haiduong Provincial General Hospital

Main Article Content

Abstract

Background: Antimicrobial resistance is a critical public health concern, compromising treatment efficacy and increasing mortality rates. Among bacterial pathogens, gram-negative bacilli of intestinal origin are showing arising trend of resistance, particularly to β-lactam antibiotics. This study aimed to investigate the distribution and β-lactam resistance patterns of Enterobacteriaceae isolated at Hai Duong General Hospital. Methods: A retrospective study was conducted using culture, bacterial identification, and antimicrobial susceptibility data from the Microbiology Department between 2020 and 2022. Eligible isolates included members of the Enterobacteriaceae family subjected to susceptibility testing. Results: A total of 4,953 Enterobacteriaceae isolates were recovered, predominantly Escherichia coli (52.6%) and Klebsiella pneumoniae (38.7%). Infection rates were higher among male patients (61.4%) and individuals aged ≥46, particularly those in the 61–75 age group. Most isolates were obtained from pus samples (46.15%) and from patients in Surgical, Internal Medicine, and Intensive Care units. The overall prevalence of ESBL-producing strains was 29.15%, with E. coli accounting for 40.29% of these. E. coli exhibited high resistance to ampicillin (88.91%) and third-generation cephalosporins (>50%), while maintaining susceptibility to carbapenems (<3%). K. pneumoniae showed substantial resistance to piperacillin and cephalosporins (>40%). Proteus spp. and other Enterobacteriaceae exhibited moderate resistance levels but remained highly susceptible to carbapenems. Conclusion: E. coli and K. pneumoniae were the predominant pathogens, demonstrating considerable β-lactam resistance. These findings highlight the urgent need for antimicrobial stewardship and resistance surveillance in clinical settings.

Article Details

References

1. World Health Organization. Antimicrobial resistance: global report on surveillance 2014. Geneva: WHO; 2014.
2. Cunha BA. Antibiotic Essentials 15th Edition. Jaypee Brothers Medical Publishers; 2017. p. 205–210.
3. Ramatla T, Mafokwane T, Lekota KL, et al. One‑Health perspective on prevalence of co‑existing extended‑spectrum ß‑lactamase (ESBL)‑producing Escherichia coli and Klebsiella pneumoniae: a comprehensive systematic review and meta‑analysis. Ann Clin Microbiol Antimicrob. 2023;22(1):40. doi:10.1186/s12941-023-00638-3.
4. Nguyễn Vĩnh Nghi, Lê Huy Thạch, Nguyễn Huỳnh Như Ý, Nguyễn Quang Trung, Lê Tân Thanh. Khảo sát tình hình kháng kháng sinh của các vi khuẩn gram âm đường ruột thường gặp tại Bệnh viện tỉnh Ninh Thuận. Tạp chí Y học Việt Nam. 2021;503(1):113–118.
5. Nguyễn Trung Bình, Trần Đỗ Hùng. Tình hình đề kháng kháng sinh của vi khuẩn đường ruột sinh ESBL tại Bệnh viện Đa khoa Trung tâm An Giang năm 2020–2021. Tạp chí Y Dược học Cần Thơ, 43, 215-223.
6. Nguyễn, H. N. T., Nguyễn, Q. H., & Nguyễn, M. H. (2024). Tình hình kháng Carbapenem của họ vi khuẩn Enterobacteriaceae tại Bệnh viện Nguyễn Tri Phương giai đoạn 2019–2023. Tạp chí Y học Việt Nam, 537(1B), 1–8.
7. Bezabih YM, Sabiiti W, Alamneh E, Bezabih A, Peterson GM, Bezabhe WM, Roujeinikova A. The global prevalence and trend of human intestinal carriage of ESBL-producing Escherichia coli in the community. J Antimicrob Chemother. 2021;76(1): 22–29. https://doi.org/10.1093/jac/ dkaa399
8. Nguyễn Quang Huy, Lê Thị Thu Ngân, Võ Thị Hà, Nguyễn Minh Hà. Tình hình đề kháng kháng sinh của Klebsiella pneumoniae tại Bệnh viện Nguyễn Tri Phương giai đoạn 2019–2022. Tạp chí Y học TP. Hồ Chí Minh. 2023;27(1):39–45.